Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol

Their formulas are produced in FDA-registered, NSF GMP-certified facilities with controls designed to support consistency, purity, identity, and traceability across production batches, as outlined in the NuMedica company profile
The hero ingredient, glutathione, is a brightening antioxidant that reduces the appearance of fine lines and wrinkles
TB-500 is a synthetic version of Thymosin Beta-4 , a naturally occurring peptide in humans
If the levels of myoinositol are too low, miscarriage of pregnancy will occur
This is incredibly important, as it keeps your reconstituted peptide safe for repeated use over several weeks